Latest Insider Transactions at Hologic Inc (HOLX)
This section provides a real-time view of insider transactions for Hologic Inc (HOLX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of HOLOGIC INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of HOLOGIC INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 11
2022
|
Stephen P Macmillan Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
138,422
-1.84%
|
$10,381,650
$75.72 P/Share
|
|
Nov 11
2022
|
Stephen P Macmillan Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
95,422
+3.62%
|
$2,480,972
$26.21 P/Share
|
|
Nov 11
2022
|
Benjamin Jordan Cohn Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
322
-2.22%
|
$24,150
$75.93 P/Share
|
|
Nov 09
2022
|
John M. Griffin General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
609
-0.33%
|
$43,848
$72.11 P/Share
|
|
Nov 09
2022
|
Elisabeth A Hellmann SVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
194
-1.82%
|
$13,968
$72.11 P/Share
|
|
Nov 09
2022
|
Essex D Mitchell Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
201
-2.03%
|
$14,472
$72.11 P/Share
|
|
Nov 09
2022
|
Kevin R Thornal Group Pres, Global Diagnostics |
SELL
Payment of exercise price or tax liability
|
Direct |
591
-0.75%
|
$42,552
$72.11 P/Share
|
|
Nov 09
2022
|
Jan Verstreken Group President, International |
SELL
Payment of exercise price or tax liability
|
Direct |
135
-0.17%
|
$9,720
$72.11 P/Share
|
|
Nov 09
2022
|
Karleen Marie Oberton Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
680
-0.51%
|
$48,960
$72.11 P/Share
|
|
Nov 09
2022
|
Stephen P Macmillan Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,776
-0.23%
|
$415,872
$72.11 P/Share
|
|
Nov 09
2022
|
Erik S Anderson Div. Pres., Breast & Skeletal |
SELL
Payment of exercise price or tax liability
|
Direct |
131
-1.21%
|
$9,432
$72.11 P/Share
|
|
Nov 09
2022
|
Benjamin Jordan Cohn Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
215
-1.46%
|
$15,480
$72.11 P/Share
|
|
Nov 08
2022
|
Jan Verstreken Group President, International |
SELL
Payment of exercise price or tax liability
|
Direct |
194
-0.24%
|
$14,162
$73.71 P/Share
|
|
Nov 08
2022
|
Jan Verstreken Group President, International |
BUY
Grant, award, or other acquisition
|
Direct |
6,724
+7.67%
|
-
|
|
Nov 08
2022
|
Karleen Marie Oberton Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
688
-0.51%
|
$50,224
$73.71 P/Share
|
|
Nov 08
2022
|
Karleen Marie Oberton Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,565
+5.33%
|
-
|
|
Nov 08
2022
|
Stephen P Macmillan Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,052
-0.16%
|
$295,796
$73.71 P/Share
|
|
Nov 08
2022
|
Kevin R Thornal Group Pres, Global Diagnostics |
SELL
Payment of exercise price or tax liability
|
Direct |
709
-0.9%
|
$51,757
$73.71 P/Share
|
|
Nov 08
2022
|
Erik S Anderson Div. Pres., Breast & Skeletal |
SELL
Payment of exercise price or tax liability
|
Direct |
126
-1.15%
|
$9,198
$73.71 P/Share
|
|
Nov 08
2022
|
Benjamin Jordan Cohn Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
207
-1.38%
|
$15,111
$73.71 P/Share
|
|
Nov 08
2022
|
John M. Griffin General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
602
-0.33%
|
$43,946
$73.71 P/Share
|
|
Nov 08
2022
|
Elisabeth A Hellmann SVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
243
-2.23%
|
$17,739
$73.71 P/Share
|
|
Nov 08
2022
|
Essex D Mitchell Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
322
-3.15%
|
$23,506
$73.71 P/Share
|
|
Nov 08
2022
|
Essex D Mitchell Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,034
+28.28%
|
-
|
|
Nov 07
2022
|
Stephen P Macmillan Chairman, President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
36,987
+1.46%
|
-
|
|
Nov 07
2022
|
Kevin R Thornal Group Pres, Global Diagnostics |
BUY
Grant, award, or other acquisition
|
Direct |
6,724
+7.84%
|
-
|
|
Nov 07
2022
|
Erik S Anderson Div. Pres., Breast & Skeletal |
BUY
Grant, award, or other acquisition
|
Direct |
3,362
+23.49%
|
-
|
|
Nov 07
2022
|
Benjamin Jordan Cohn Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,176
+7.29%
|
-
|
|
Nov 07
2022
|
John M. Griffin General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
6,052
+3.2%
|
-
|
|
Nov 07
2022
|
Elisabeth A Hellmann SVP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
2,353
+17.73%
|
-
|
|
Nov 01
2022
|
John M. Griffin General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
19,642
+9.98%
|
-
|
|
Nov 01
2022
|
Kevin R Thornal Group Pres, Global Diagnostics |
BUY
Grant, award, or other acquisition
|
Direct |
12,277
+14.51%
|
-
|
|
Nov 01
2022
|
Jan Verstreken Group President, International |
BUY
Grant, award, or other acquisition
|
Direct |
10,436
+12.32%
|
-
|
|
Nov 01
2022
|
Karleen Marie Oberton Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
14,545
-10.29%
|
$1,047,240
$72.5 P/Share
|
|
Nov 01
2022
|
Karleen Marie Oberton Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,545
+5.02%
|
$552,710
$38.8 P/Share
|
|
Nov 01
2022
|
Karleen Marie Oberton Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,872
+14.13%
|
-
|
|
Nov 01
2022
|
Stephen P Macmillan Chairman, President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
103,447
+4.04%
|
-
|
|
Jul 01
2022
|
Jan Verstreken Group President, International |
SELL
Payment of exercise price or tax liability
|
Direct |
359
-0.56%
|
$25,130
$70.14 P/Share
|
|
May 17
2022
|
Benjamin Jordan Cohn Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
3,844
-22.12%
|
$299,832
$78.75 P/Share
|
|
May 17
2022
|
Benjamin Jordan Cohn Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,844
+18.12%
|
$153,760
$40.85 P/Share
|
|
May 17
2022
|
Jan Verstreken Group President, International |
SELL
Open market or private sale
|
Direct |
6,500
-9.19%
|
$507,000
$78.8 P/Share
|
|
May 13
2022
|
Benjamin Jordan Cohn Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
7,052
-20.64%
|
$528,900
$75.49 P/Share
|
|
May 13
2022
|
Benjamin Jordan Cohn Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,052
+17.1%
|
$275,028
$39.24 P/Share
|
|
May 03
2022
|
Benjamin Jordan Cohn Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
2,178
-13.86%
|
$161,172
$74.18 P/Share
|
|
Mar 10
2022
|
Sally Crawford Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,565
+1.19%
|
-
|
|
Mar 10
2022
|
Scott T Garrett Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,565
+2.33%
|
-
|
|
Mar 10
2022
|
Ludwig Hantson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,565
+16.27%
|
-
|
|
Mar 10
2022
|
Charles J Dockendorff Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,565
+22.93%
|
-
|
|
Mar 10
2022
|
Namal Nawana Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,565
+8.54%
|
-
|
|
Mar 10
2022
|
Christiana Stamoulis Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,565
+3.56%
|
-
|